Alzamend Neuro ALZN
NASDAQ ALZN
$1.37 +0.05 (+3.79%)
At close: Oct 2, 2026 · 4:00 PM EDT

Alzamend Neuro (ALZN) Invested Capital (2024)

Updated

Alzamend Neuro's Invested Capital was -$2.29 million in fiscal Q4 2024 (quarter ended Apr 30, 2024).

Analysis

Alzamend Neuro (ALZN) Invested Capital (2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 88.79 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 134.01 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 64.89 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 95.89 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 79.44 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 50.26 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 68.99 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 38.08 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 148.69 Bn
10 Alzamend Neuro 6.61 Mn 6.61 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Apr 30, 2024 -2.29 Mn
API Access

Alzamend Neuro Invested Capital API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=invested-capital&ticker=ALZN&period=max&api_key=YOUR_API_KEY